Stocks News

LAST PRICE
236.4500
TODAY'S CHANGE (%)
Trending Up3.3800 (1.4502%)

Bid / Lots
231.0000/ 4
Ask / Lots
241.8600/ 1
Open / Previous Close
232.3600 / 233.0700
Day Range
Low 231.9300
High 236.5400
52 Week Range
Low 148.0000
High 277.3400
Volume
318,792
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 5, 2024
- New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options, from 9:01AM ET on Tuesday Nov 05, 2024 by PR Newswire
  9:01AM ET on Tuesday Nov 05, 2024 by PR Newswire
  Companies Mentioned: PEN
  -- Data presented for the first time this week at Vascular Interventional Advances (VIVA) 2024 Conference
  -- Findings reinforce the clinical, health economic and cost benefits of computer assisted vacuum thrombectomy to patients and the overall health system
- New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options, from 9:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
  9:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: PEN
  
  New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
Oct 31, 2024
- DJ Penumbra Is Maintained at Overweight by Piper Sandler, from 2:37PM ET on Thursday Oct 31, 2024 by Dow Jones
  2:37PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: PEN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/PEN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 14:37 ET (18:37 GMT)
- DJ Penumbra Is Maintained at Outperform by Baird, from 8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
  8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: PEN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/PEN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 08:00 ET (12:00 GMT)
- Deutsche Bank Raises Price Target on Penumbra to $241 From $205, Keeps Buy Rating, from 7:54AM ET on Thursday Oct 31, 2024 by MT Newswires
  7:54AM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: PEN
  07:54 AM EDT, 10/31/2024 (MT Newswires) -- Penumbra (PEN) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $150 to $250. (MT Newswires covers equity, commodity and economic research ...

Yesterday
- Glaukos Announces Participation in Upcoming Investor Conferences, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: GKOS
Nov 7, 2024
- Teleflex to Present at the Jefferies London Healthcare Conference, from 6:30AM ET on Thursday Nov 07, 2024 by Dow Jones
  6:30AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: TFX
Nov 6, 2024
- DJ Masimo Raised to Outperform From Market Perform by Raymond James, from 1:09PM ET on Wednesday Nov 06, 2024 by Dow Jones
  1:09PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: MASI
- DJ Masimo Is Maintained at Overweight by Wells Fargo, from 10:36AM ET on Wednesday Nov 06, 2024 by Dow Jones
  10:36AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: MASI
- DJ Masimo Is Maintained at Overweight by Piper Sandler, from 8:31AM ET on Wednesday Nov 06, 2024 by Dow Jones
  8:31AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: MASI
Nov 5, 2024
- Masimo Q3 Non-GAAP Earnings, Revenue Rise; Full-year Guidance Updated, from 4:28PM ET on Tuesday Nov 05, 2024 by MT Newswires
  4:28PM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: MASI
- -- GUIDANCE: (MASI) MASIMO CORPORATION Forecasts Q4 EPS Range $1.35 - $1.50, from 4:07PM ET on Tuesday Nov 05, 2024 by MT Newswires
  4:07PM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: MASI
- -- GUIDANCE: (MASI) MASIMO CORPORATION Expects Fiscal Year 2024 EPS Range $3.95 - $4.10, from 4:06PM ET on Tuesday Nov 05, 2024 by MT Newswires
  4:06PM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: MASI
- -- Earnings Flash (MASI) MASIMO CORPORATION Reports Q3 Revenue $504.6M, from 4:06PM ET on Tuesday Nov 05, 2024 by MT Newswires
  4:06PM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: MASI
- -- GUIDANCE: (MASI) MASIMO CORPORATION Sees Q4 Revenue Range $581M - $611M, from 4:05PM ET on Tuesday Nov 05, 2024 by MT Newswires
  4:05PM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: MASI

Penumbra Inc
NYSE:PENUnited States

Search Criteria

Nov 5, 2024

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options, from 9:01AM ET on Tuesday Nov 05, 2024 by PR Newswire

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options, from 9:00AM ET on Tuesday Nov 05, 2024 by Dow Jones

Oct 31, 2024

DJ Penumbra Is Maintained at Overweight by Piper Sandler, from 2:37PM ET on Thursday Oct 31, 2024 by Dow Jones

DJ Penumbra Is Maintained at Outperform by Baird, from 8:00AM ET on Thursday Oct 31, 2024 by Dow Jones

Deutsche Bank Raises Price Target on Penumbra to $241 From $205, Keeps Buy Rating, from 7:54AM ET on Thursday Oct 31, 2024 by MT Newswires

Peers Headlines

Yesterday

Glaukos Announces Participation in Upcoming Investor Conferences, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

Teleflex to Present at the Jefferies London Healthcare Conference, from 6:30AM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

DJ Masimo Raised to Outperform From Market Perform by Raymond James, from 1:09PM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ Masimo Is Maintained at Overweight by Wells Fargo, from 10:36AM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ Masimo Is Maintained at Overweight by Piper Sandler, from 8:31AM ET on Wednesday Nov 06, 2024 by Dow Jones

Nov 5, 2024

Masimo Q3 Non-GAAP Earnings, Revenue Rise; Full-year Guidance Updated, from 4:28PM ET on Tuesday Nov 05, 2024 by MT Newswires

-- GUIDANCE: (MASI) MASIMO CORPORATION Forecasts Q4 EPS Range $1.35 - $1.50, from 4:07PM ET on Tuesday Nov 05, 2024 by MT Newswires

-- GUIDANCE: (MASI) MASIMO CORPORATION Expects Fiscal Year 2024 EPS Range $3.95 - $4.10, from 4:06PM ET on Tuesday Nov 05, 2024 by MT Newswires

-- Earnings Flash (MASI) MASIMO CORPORATION Reports Q3 Revenue $504.6M, from 4:06PM ET on Tuesday Nov 05, 2024 by MT Newswires

-- GUIDANCE: (MASI) MASIMO CORPORATION Sees Q4 Revenue Range $581M - $611M, from 4:05PM ET on Tuesday Nov 05, 2024 by MT Newswires